| Article
>Drug testing is part of a complete patient evaluation and ongoing risk monitoring in most medical practice settings when treatment involves long-term use of controlled medication. Today’s licensing board guidelines and rules, and position papers published by professional societies, make clear that...
| Article
Why yet another lecture on migraine headaches, you ask? Migraine is the third most common disease in the world (behind dental caries and tension-type headache) with an estimated global prevalence of approximately 15% (that's around 1 in 7 people). Migraine is more prevalent than diabetes, epilepsy...
| Article
The subject of the medical use of cannabinoids has become an extremely hot topic. Unfortunately, there has been a tendency to equate medical cannabinoids with another very contentious topic: Medical Marijuana. In this presentation, the distinction between medical cannabinoids and medical cannabis...
| Article
Lunch will be served.
Sponsored by Teva Pharmaceuticals.
| Article
Through the lens of medical expert testimony and case examples, attendees will learn core areas of risk mitigation with a focus on making electronic medical records and paper charting work for the practitioner to demonstrate prescribing in the usual course of professional practice. Overdose—a small...
| Article
Urine drug testing (UDT) is playing an increasing role in the management of risk in clinical care. Unfortunately, drug testing in general suffers from several shortcomings, especially when called upon to identify problematic use of controlled substances, including drug diversion. UDT is the...